Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2025-12-25 @ 12:35 AM
NCT ID:
NCT00837967
Eligibility Criteria:
Inclusion Criteria:
* Provision of informed consent prior to any study specific procedures
* A minimum of 6 months documented history of asthma according to the JGL2006/GINA2006 definition
* FEV1\> 70% of predicted normal value pre-bronchodilator
Exclusion Criteria:
* Having a known or suspected allergy to study therapy (active drugs or additive)
* Having a known clinical history of hypertension, relevant arrhythmias or other heart disease, eg, ischemic heart disease, cardiomyopathy, valvular heart disease, or heart failure
* Having been treated with oral, parenteral or rectal glucocorticoids within 4 weeks, or with depot parenteral glucocorticoids within 3 months
* Respiratory infection significantly affecting the asthma, as judged by the investigator within 4 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
65 Years
Study:
NCT00837967
Study Brief:
Protocol Section:
NCT00837967